Total Holdings
40
Portfolio diversification across 40 positions
GDOC
(NYSEARCA)Future Health Care Equity ETF
$34.61-- (--)
Loading... - Market loading
GDOC ETF Holdings: Future Health Care Equity ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$21.23M
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
Goldman Sachs
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 45 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 12.15% |
| 2 |  | Johnson & Johnson | Stock | 7.95% |
| 3 |  | Boston Scientific Corporation | Stock | 7.38% |
| 4 |  | Thermo Fisher Scientific Inc. | Stock | 6.82% |
| 5 | L LON:AZN | AstraZeneca PLC | Stock | 5.95% |
| 6 |  | AbbVie Inc | Stock | 5.62% |
| 7 | L LSE:AZN | AstraZeneca PLC | Stock | 5.50% |
| 8 |  | Abbott Laboratories | Stock | 5.31% |
| 9 |  | Intuitive Surgical, Inc | Stock | 4.95% |
| 10 |  | Insulet Corporation | Stock | 4.03% |
| 11 |  | Guardant Health, Inc. | Stock | 4.01% |
| 12 |  | argenx SE | Stock | 3.96% |
| 13 | T TYO:7741 | HOYA Corporation | Stock | 3.53% |
| 14 |  | Agilent Technologies, Inc | Stock | 3.42% |
| 15 |  | Cencora, Inc. | Stock | 3.36% |
| 16 | T TSE:7741 | Hoya Cor | Stock | 3.03% |
| 17 | S SWX:LONN | Lonza Group AG | Stock | 2.89% |
| 18 |  | DexCom, Inc. | Stock | 2.62% |
| 19 |  | Neurocrine Biosciences, Inc | Stock | 2.52% |
| 20 |  | Veeva Systems Inc | Stock | 2.34% |
| 21 | F FTOXX | Goldman Sachs FS Treasury Obligs Instl | Stock | 1.98% |
| 22 |  | BioMarin Pharmaceutical Inc | Stock | 1.96% |
| 23 |  | Mettler-Toledo International Inc. | Stock | 1.85% |
| 24 |  | Danaher Corporation | Stock | 1.76% |
| 25 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.73% |
| 26 |  | Madrigal Pharmaceuticals, Inc | Stock | 1.73% |
| 27 |  | Roivant Sciences Ltd. | Stock | 1.67% |
| 28 |  | Insmed Incorporated | Stock | 1.66% |
| 29 | E EPA:DIM | Sartorius Stedim Biotech S.A. | Stock | 1.61% |
| 30 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 1.53% |
| 31 |  | Apogee Therapeutics, Inc. | Stock | 1.48% |
| 32 |  | Qiagen N.V. | Stock | 1.47% |
| 33 |  | Repligen Corporation | Stock | 1.40% |
| 34 |  | Penumbra, Inc. | Stock | 1.17% |
| 35 |  | Natera, Inc | Stock | 1.10% |
| 36 |  | UnitedHealth Group Incorporated | Stock | 1.10% |
| 37 |  | Xenon Pharmaceuticals Inc | Stock | 0.99% |
| 38 |  | Revolution Medicines, Inc | Stock | 0.82% |
| 39 |  | iRhythm Technologies, Inc | Stock | 0.70% |
| 40 |  | West Pharmaceutical Services, Inc | Stock | 0.67% |
| 41 |  | Cytokinetics, Incorporated | Stock | 0.58% |
| 42 |  | CG Oncology, Inc. Common stock | Stock | 0.52% |
| 43 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.51% |
| 44 |  | GeneDx Holdings Corp. | Stock | 0.47% |
| 45 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.44% |